Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02671669 |
Recruitment Status :
Completed
First Posted : February 2, 2016
Last Update Posted : May 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiac Disease Pulmonary Disease Cardiopulmonary Disease | Behavioral: Usual Care Behavioral: Movn application (MVN) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 67 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Prevention |
Official Title: | Empowering Individuals Post-Cardiopulmonary Outpatient Rehabilitation to Continue to Live a Heart Healthy Lifestyle: Utilizing Mobile Health Technology |
Actual Study Start Date : | January 2016 |
Actual Primary Completion Date : | August 31, 2017 |
Actual Study Completion Date : | March 1, 2018 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Usual Care (UC) |
Behavioral: Usual Care
Discharge packet of Heart Healthy instructions, with self-report health status, quality of life and psychosocial questionnaires, as well as other educational handouts, exit interview to review exercise progress, receive referrals to additional medical services they might need after discharge from the program, with physician. |
Active Comparator: Movn application (MVN) |
Behavioral: Movn application (MVN)
Intervention participants will receive the same discharge packet as the UC group along with their exit interview and will receive the following:
|
- Difference in rate of exercise compliance in standard post cardiac rehabilitation compared to the increased rates of exercise compliance observed with the help of smartphone applications [ Time Frame: 6 Months ]
- Difference in Diastolic blood pressure in subjects who have received andard post cardiac rehabilitation compared to of exercise compliance observed with the help of smartphone applications [ Time Frame: 6 Months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Current participants in The Joan and Joel Smilow Cardiac Rehabilitation and Prevention Center (JJCRPC) of Rusk Rehabilitation Patient within two weeks of completing outpatient cardiac rehabilitation
- Clinically stable: moderate to low risk strata by standardized clinical assessment
- Clinically stable: moderate to low risk strata by standardized clinical assessment
- no infections
- no unstable arrhythmias, aortic stenosis, thrombophlebitis, dissecting aneurysm or symptomatic anemia
- controlled blood pressure-resting diastolic <100 mmHg, systolic <180mmHg
- no uncompensated heart failure NYHA Class 3-4
- stable angina (no chest pain for month)
- no 2nd or 3rd degree heart block
- no uncontrolled high grade exercise induced ventricular ectopy-hemodynamically stable
- Own an iPhone (version 3 or above), an iPad, or an iPod touch (version 4 or higher) or Android phone or tablet
- Ability to use and comfortable with using mobile health technology to monitor physical and psychosocial health
- Is comfortable using mobile applications
- English language fluency
- Ability to provide informed consent
Exclusion Criteria:
- Patients who do not fulfill all inclusion criteria stated above.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02671669
United States, New York | |
New York University School of Medicine | |
New York, New York, United States, 10016 |
Principal Investigator: | Tamara Bushnik, MD | New York University Medical School |
Responsible Party: | NYU Langone Health |
ClinicalTrials.gov Identifier: | NCT02671669 |
Other Study ID Numbers: |
14-01809 |
First Posted: | February 2, 2016 Key Record Dates |
Last Update Posted: | May 22, 2020 |
Last Verified: | May 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Heart Diseases Pulmonary Heart Disease Cardiovascular Diseases |